The core activity of MetrioPharm AG is the development of medications against chronic inflammatory diseases such as psoriasis, arthritis and multiple sclerosis.
AI-generated
Comparisons
MetrioPharm AG in comparison
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.